Reversal Agents for the New Generation of Oral Anticoagulants: Implications for the Perioperative Physician

被引：10

作者：

Lohrmann, Graham M. ^{[1
]}

Atwal, Danish ^{[1
]}

Augoustides, John G. ^{[2
]}

Askar, Wajih ^{[3
]}

Patel, Prakash A. ^{[2
]}

Ghadimi, Kamrouz ^{[4
,5
]}

Makar, Gerges ^{[1
]}

Gutsche, Jacob T. ^{[2
]}

Shamoun, Fadi E. ^{[1
]}

Ramakrishna, Harish ^{[3
]}

机构：

[1] Mayo Clin, Div Cardiovasc Dis, Scottsdale, AZ USA

[2] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA

[3] Mayo Clin, Dept Anesthesiol, Scottsdale, AZ USA

[4] Duke Univ, Med Ctr, Div Cardiothorac Anesthesiol, Durham, NC USA

[5] Duke Univ, Med Ctr, Div Crit Care, Durham, NC USA

来源：

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA | 2016年 / 30卷 / 03期

关键词：

novel oral anticoagulants; dabigatran; rivaroxaban; edoxaban; apixaban; direct thrombin inhibitor; factor Xa; atrial fibrillation; activated charcoal; prothrombin complex concentrates; vitamin K antagonists; warfarin; recombinant factor VIM; idarucizumab; andexanet; aripazine; PROTHROMBIN COMPLEX CONCENTRATE; ACTIVATED FACTOR-VII; RECOMBINANT-FACTOR-VIIA; ATRIAL-FIBRILLATION; DABIGATRAN ETEXILATE; CARDIAC-SURGERY; CLINICAL-TRIAL; IDARUCIZUMAB; WARFARIN; RIVAROXABAN;

D O I：

10.1053/j.jvca.2016.01.005

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

[No abstract available]

引用

页码：823 / 830

页数：8

共 50 条

[21] REVERSAL AGENTS FOR THE DIRECT ORAL ANTICOAGULANTS [J].

Ageno, W. .

BLOOD TRANSFUSION, 2016, 14 :S706-S709

[22] A New Generation of Oral Direct Anticoagulants [J].

Soff, Gerald A. .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (03) :569-574

[23] New oral anticoagulants and their reversal agents [J].

Laslo, Crista L. ;

Stoian, Anca Pantea ;

Socea, Bogdan ;

Paduraru, Dan N. ;

Bodean, Oana ;

Socea, Laura I. ;

Neagu, Tiberiu Paul ;

Stanescu, Ana Maria Alexandra ;

Marcu, Drags ;

Diaconu, Camelia C. .

JOURNAL OF MIND AND MEDICAL SCIENCES, 2018, 5 (02) :195-201

[24] Reversal agents for direct oral anticoagulants: A focused review [J].

Arbit, Boris ;

Nishimura, Marin ;

Hsu, Jonathan C. .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 223 :244-250

[25] Reversal of target-specific oral anticoagulants [J].

Kaatz, Scott ;

Crowther, Mark .

JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2013, 36 (02) :195-202

[26] Reversal of novel oral anticoagulants [J].

Abo-Salem, Elsayed ;

Becker, Richard C. .

CURRENT OPINION IN PHARMACOLOGY, 2016, 27 :86-91

[27] Reversal of New Oral Anticoagulants [J].

Battinelli, Elisabeth M. .

CIRCULATION, 2011, 124 (14) :1508-1510

[28] New oral anticoagulants in elderly patients [J].

Barco, Stefano ;

Cheung, Yuk Wah ;

Eikelboom, John W. ;

Coppens, Michiel .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (02) :215-224

[29] Hemorrhagic stroke and new oral anticoagulants [J].

Derlon, V. ;

Corbonnois, G. ;

Martin, M. ;

Toussaint-Hacquard, M. ;

Audibert, G. .

ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2014, 33 (9-10) :540-547

[30] Monitoring and reversal strategies for new oral anticoagulants [J].

Vanden Daelen, Sophie ;

Peetermans, Marijke ;

Vanassche, Thomas ;

Verhamme, Peter ;

Vandermeulen, Erik .

EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (01) :95-103

← 1 2 3 4 5 →